Genentech

Genentech, Inc. has appointed Leonard Kanavy vice president, commercial operations and has promoted Anthony P. Hurley to vice president, fill/finish manufacturing.

Mr. Kanavy will report to Ian T. Clark, executive vice president, commercial operations. In this role, he will be responsible for leading the market planning, forecasting, sales operations, data acquisition, commercial training, commercial business processes, thought leader management and market communications groups.

Mr. Kanavy joins the company from Novartis Pharmaceuticals, U.S. where he was vice president of commercial operations. He held several leadership roles at Novartis, including vice president of business analysis, executive director of market analysis, and director of specialty marketing research and analysis.

Mr. Hurley will report to Timothy L. Moore vice president, South San Francisco manufacturing. In this role, he will continue to lead the South San Francisco (SSF) commercial and clinical fill/finish operations, and will have overall responsibility for Genentech’s future fill/finish facility in Hillsboro, OR, which is expected to be licensed and operational in 2010.

Mr. Hurley joined the company in 2005 as senior director, parenteral manufacturing facility. He has had increasing responsibilities, including leading the packaging operations, and most recently, the SSF manufacturing and utility instrumentations operations teams.

Prior to joining the company, Mr. Hurley was site director for GlaxoSmith Kline’s anti-infectives operation and held various manufacturing operations and strategic planning positions during his 17 years’ with the company.